Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C

被引:7
|
作者
Denise C Paranaguá-Vezozzo [1 ]
Adriana Andrade [1 ]
Daniel F C Mazo [1 ,2 ]
Vinicius Nunes [1 ]
Ana L Guedes [1 ]
Taisa G Ragazzo [1 ]
Renata Moutinho [1 ]
Lucas S Nacif [1 ]
Suzane K Ono [1 ]
Venancio A F Alves [3 ]
Flair J Carrilho [1 ]
机构
[1] Division of Clinical Gastroenterology and Hepatology,Hospital das Clínicas,Department of Gastroenterology,University of S?o Paulo School of Medicine
[2] Division of Gastroenterology,School of Medical Sciences,State University of Campinas
[3] Department of Pathology,University of S?o Paulo School of Medicine
关键词
Elastography; Serum markers; Hepatitis C virus; Liver stiffness; Liver biopsy;
D O I
暂无
中图分类号
R512.63 []; R575.2 [肝硬变];
学科分类号
1002 ; 100201 ; 100401 ;
摘要
AIM To determine the sensitivity and specificity of liver stiffness measurement(LSM) and serum markers(SM) for liver fibrosis evaluation in chronic hepatitis C.METHODS Between 2012 and 2014,81 consecutive hepatitis C virus(HCV) patients had METAVIR score from liver biopsy compared with concurrent results from LSM [transient elastography(TE) [FibroS can;/ARFI technology(Virtual Touch;)] and SM [FIB-4/aspartate aminotransferase-toplatelet ratio index(APRI)].The diagnostic performance of these tests was assessed using receiver operating characteristic curves.The optimal cut-off levels of each test were chosen to define fibrosis stages F ≥ 2,F ≥ 3 and F = 4.The Kappa index set the concordance analysis.RESULTS Fifty point six percent were female and the median age was 51 years(30-78).Fifty-six patients(70%) weretreatment-na?ve.The optimal cut-off values for predicting F ≥ 2 stage fibrosis assessed by TE were 6.6 kP a,for acoustic radiation force impulse(ARFI) 1.22 m/s,for APRI 0.75 and for FIB-4 1.47.For F ≥ 3 TE was 8.9 kP a,ARFI was 1.48 m/s,APRI was 0.75,and FIB-4 was 2.For F = 4,TE was 12.2 kP a,ARFI was 1.77 m/s,APRI was 1.46,and FIB-4 was 3.91.The APRI could not distinguish between F2 and F3,P = 0.92.The negative predictive value for F = 4 for TE and ARFI was 100%.Kappa index values for F ≥ 3 METAVIR score for TE,ARFI and FIB-4 were 0.687,0.606 and 0.654,respectively.This demonstrates strong concordance between all three screening methods,and moderate to strong concordance between them and APRI(Kappa index = 0.507).CONCLUSION Given the costs and accessibility of LSM methods,and the similarity with the outcomes of SM,we suggest that FIB-4 as well as TE and ARFI may be useful indicators of the degree of liver fibrosis.This is of particular importance to developing countries.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 50 条
  • [41] Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients
    Patel, K
    Gordon, SC
    Jacobson, I
    Hézode, C
    Oh, E
    Smith, KM
    Pawlotsky, JM
    McHutchison, JG
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (06) : 935 - 942
  • [42] Non-Invasive Diagnosis of Liver Fibrosis in Chronic Hepatitis C using Mathematical Modeling and Simulation
    Shukla, Nehal
    Angelopoulou, Anastasia
    Hodhod, Rania
    [J]. ELECTRONICS, 2022, 11 (08)
  • [43] Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients
    Stibbe, Krista J. M.
    Verveer, Claudia
    Francke, Jan
    Hansen, Bettina E.
    Zondervan, Pieter E.
    Kuipers, Ernst J.
    de Knegt, Robert J.
    van Vuuren, Anneke J.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (7-8) : 962 - 972
  • [44] Are non-invasive biochemical markers useful in the assessment liver fibrosis in patients with chronic hepatitis C?
    Urda, Jose Luis Castro
    Vicente, Cristina
    Quintanilla, Elvira
    Moran, Marta
    Collado, David
    Guerra, Ivan
    Rabago, Luis R.
    Gea, Francisco
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A797 - A797
  • [45] Impact of antiviral treatment on non-invasive predictors of liver fibrosis in patients with chronic hepatitis C
    Martinez, Stella M.
    Fernandez-Varo, Guillermo
    Dominguez, Marlene
    Bataller, Ramon
    Sampson, Ellen
    Jimenez, Wladimiro
    Sanchez-Tapias, Jose M.
    Forns, Xavier
    [J]. HEPATOLOGY, 2007, 46 (04) : 369A - 369A
  • [46] VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C
    Hassan, Elham Ahmed
    Abd El-Rehim, Abeer Sharaf El-Din
    Sayed, Zain El-Abdeen Ahmed
    Kholef, Emad Farah Mohamed
    Sabry, Abeer
    Abo Elhagag, Noha Abd El-Rehim
    [J]. HEPATOLOGY RESEARCH, 2017, 47 (13) : 1408 - 1416
  • [47] Assessment of Eight Non-Invasive Markers of Liver Fibrosis in Egyptian Patients With Chronic Hepatitis C
    Atta, Mohamed Magdi E.
    El Sharkawy, Entesar H.
    Said, Ebada
    El Feky, Halo M.
    El Toukhy, Naglaa
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S457 - S457
  • [48] The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
    Lee, Jia-Jung
    Wei, Yu-Ju
    Lin, Ming-Yen
    Niu, Sheng-Wen
    Hsu, Po-Yao
    Huang, Jiun-Chi
    Jang, Tyng-Yuan
    Yeh, Ming-Lun
    Huang, Ching-, I
    Liang, Po-Cheng
    Lin, Yi-Hung
    Hsieh, Ming-Yen
    Hsieh, Meng-Hsuan
    Chen, Szu-Chia
    Dai, Chia-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Chang, Jer-Ming
    Hwang, Shang-Jyh
    Huang, Chung-Feng
    Chiu, Yi-Wen
    Chuang, Wan-Long
    Yu, Ming-Lung
    [J]. PLOS ONE, 2020, 15 (11):
  • [49] Prospective Non-Invasive Follow-Up of Liver Fibrosis in Patients with Chronic Hepatitis C
    Crisan, Dana
    Radu, Corina
    Grigorescu, Mircea Dan
    Lupsor, Monica
    Feier, Diana
    Grigorescu, Mircea
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (04) : 375 - 382
  • [50] Validation of Three Non-Invasive Markers in Assessing the Severity of Liver Fibrosis in Chronic Hepatitis C
    Shaikh, Samiullah
    Memon, Muhammad Sadik
    Ghani, Hanif
    Baloch, Ghulam Hussain
    Jaffery, Mukhtiar
    Shaikh, Khalid
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2009, 19 (08): : 478 - 482